197 related articles for article (PubMed ID: 21094191)
41. Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition.
Alanazi SA; Harisa GI; Badran MM; Alanazi FK; Elzayat E; Alomrani AH; Al Meanazel OT; Al Meanazel AT
Bioengineered; 2021 Dec; 12(1):914-926. PubMed ID: 33678142
[TBL] [Abstract][Full Text] [Related]
42. Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo.
Wang M; Yuan Y; Gao Y; Ma HM; Xu HT; Zhang XN; Pan WS
Drug Dev Ind Pharm; 2012 Sep; 38(9):1134-41. PubMed ID: 22182601
[TBL] [Abstract][Full Text] [Related]
43. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
Jain S; Kumar D; Swarnakar NK; Thanki K
Biomaterials; 2012 Oct; 33(28):6758-68. PubMed ID: 22748771
[TBL] [Abstract][Full Text] [Related]
44. In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of modulated 5-fu: impact on efficacy and toxicity.
Fanciullino R; Mollard S; Giacometti S; Berda-Haddad Y; Chefrour M; Aubert C; Iliadis A; Ciccolini J
Pharm Res; 2013 May; 30(5):1281-90. PubMed ID: 23386105
[TBL] [Abstract][Full Text] [Related]
45. Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.
Semple SC; Leone R; Wang J; Leng EC; Klimuk SK; Eisenhardt ML; Yuan ZN; Edwards K; Maurer N; Hope MJ; Cullis PR; Ahkong QF
J Pharm Sci; 2005 May; 94(5):1024-38. PubMed ID: 15793796
[TBL] [Abstract][Full Text] [Related]
46. Development of stealth liposome formulation of 2'-deoxyinosine as 5-fluorouracil modulator: in vitro and in vivo study.
Fanciullino R; Giacometti S; Aubert C; Fina F; Martin PM; Piccerelle P; Ciccolini J
Pharm Res; 2005 Dec; 22(12):2051-7. PubMed ID: 16222443
[TBL] [Abstract][Full Text] [Related]
47. Strategy for chemotherapeutic delivery using a nanosized porous metal-organic framework with a central composite design.
Li Y; Li X; Guan Q; Zhang C; Xu T; Dong Y; Bai X; Zhang W
Int J Nanomedicine; 2017; 12():1465-1474. PubMed ID: 28260892
[TBL] [Abstract][Full Text] [Related]
48. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
[TBL] [Abstract][Full Text] [Related]
49. Development and evaluation of novel microemulsion based oral formulations of 5-fluorouracil using non-everted rat intestine sac model.
Shishu ; Kamalpreet ; Maheshwari M
Drug Dev Ind Pharm; 2012 Mar; 38(3):294-300. PubMed ID: 21864111
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of magnetic nanoparticles coated by 5-fluorouracil imprinted polymer for controlled drug delivery in mouse breast cancer model.
Hashemi-Moghaddam H; Kazemi-Bagsangani S; Jamili M; Zavareh S
Int J Pharm; 2016 Jan; 497(1-2):228-38. PubMed ID: 26621688
[TBL] [Abstract][Full Text] [Related]
51. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles.
Wang Y; Li P; Chen L; Gao W; Zeng F; Kong LX
Drug Deliv; 2015 Feb; 22(2):191-8. PubMed ID: 24437926
[TBL] [Abstract][Full Text] [Related]
52. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB
Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180
[TBL] [Abstract][Full Text] [Related]
53. In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system.
Bwatanglang IB; Mohammad F; Yusof NA; Abdullah J; Alitheen NB; Hussein MZ; Abu N; Mohammed NE; Nordin N; Zamberi NR; Yeap SK
J Colloid Interface Sci; 2016 Oct; 480():146-158. PubMed ID: 27428851
[TBL] [Abstract][Full Text] [Related]
54. Double loading of cyclosporine A in liposomes using cyclodextrin complexes.
Malaekeh-Nikouei B; Davies N
PDA J Pharm Sci Technol; 2009; 63(2):139-48. PubMed ID: 19634352
[TBL] [Abstract][Full Text] [Related]
55. Lactoferrin nanoparticle mediated targeted delivery of 5-fluorouracil for enhanced therapeutic efficacy.
Kumari S; Kondapi AK
Int J Biol Macromol; 2017 Feb; 95():232-237. PubMed ID: 27864056
[TBL] [Abstract][Full Text] [Related]
56. Copper-topotecan complexation mediates drug accumulation into liposomes.
Taggar AS; Alnajim J; Anantha M; Thomas A; Webb M; Ramsay E; Bally MB
J Control Release; 2006 Aug; 114(1):78-88. PubMed ID: 16842880
[TBL] [Abstract][Full Text] [Related]
57. Synthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivo.
Cheng M; Gao X; Wang Y; Chen H; He B; Li Y; Han J; Zhang Z
Int J Nanomedicine; 2013; 8():4265-76. PubMed ID: 24232303
[TBL] [Abstract][Full Text] [Related]
58. New folate receptor targeted nano liposomes for delivery of 5-fluorouracil to cancer cells: Strong implication for enhanced potency and safety.
Handali S; Moghimipour E; Kouchak M; Ramezani Z; Amini M; Angali KA; Saremy S; Dorkoosh FA; Rezaei M
Life Sci; 2019 Jun; 227():39-50. PubMed ID: 31002921
[TBL] [Abstract][Full Text] [Related]
59. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
Chandrashekar NS; Shobha Rani RH
J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
[TBL] [Abstract][Full Text] [Related]
60. A 5-fluorouracil-loaded floating gastroretentive hollow microsphere: development, pharmacokinetic in rabbits, and biodistribution in tumor-bearing mice.
Huang Y; Wei Y; Yang H; Pi C; Liu H; Ye Y; Zhao L
Drug Des Devel Ther; 2016; 10():997-1008. PubMed ID: 27042001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]